These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16193646)

  • 21. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
    Chen XX; Gao F; Wang Q; Huang X; Wang D
    Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubulins - the target for anticancer therapy.
    Vindya NG; Sharma N; Yadav M; Ethiraj KR
    Curr Top Med Chem; 2015; 15(1):73-82. PubMed ID: 25579568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of N-(arylsulfanyl)carbonyl analogues of paclitaxel (taxol).
    Karliga B; Schilling JK; Kingston DG; Bane S; Ravindra R; Talinli N
    Chem Biodivers; 2006 Apr; 3(4):396-404. PubMed ID: 17193276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.
    Banerjee A
    Biochem Biophys Res Commun; 2002 Apr; 293(1):598-601. PubMed ID: 12054644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
    Ranganathan S; Dexter DW; Benetatos CA; Hudes GR
    Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxol in the management of cancers of the breast and the ovary.
    Khayat D; Antoine EC; Coeffic D
    Cancer Invest; 2000; 18(3):242-60. PubMed ID: 10754992
    [No Abstract]   [Full Text] [Related]  

  • 27. New anti-tubulin agents.
    Felip E
    Suppl Tumori; 2002; 1(4):S17-8. PubMed ID: 12415808
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol.
    Xu K; Ludueña RF
    Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation.
    Ganesh T; Norris A; Sharma S; Bane S; Alcaraz AA; Snyder JP; Kingston DG
    Bioorg Med Chem; 2006 May; 14(10):3447-54. PubMed ID: 16434198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic chemistry. Cancer drugs better than taxol?
    Cowden CJ; Paterson I
    Nature; 1997 May; 387(6630):238-9. PubMed ID: 9153384
    [No Abstract]   [Full Text] [Related]  

  • 31. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paclitaxel (Taxol) in chemotherapy of head and neck cancer--just another proposal or breakthrough?].
    Górecka KM; Golusiński W; Gawecki W; Szyfter K
    Otolaryngol Pol; 2001; 55(5):471-6. PubMed ID: 11868318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel: a review of its pharmacology and clinical activity.
    Trudeau ME
    Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taxotere.
    Renick-Ettinger A
    J Pediatr Oncol Nurs; 1996 Jan; 13(1):43-5. PubMed ID: 8904466
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacogenomics of importance for paclitaxel chemotherapy.
    Green H
    Pharmacogenomics; 2008 Jun; 9(6):671-4. PubMed ID: 18518845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["Taxanes: an action mechanism at the cellular level, significant clinical progress in the treatment of cancers of the ovary and breast"].
    Piccart MJ
    Bull Mem Acad R Med Belg; 1998; 153(5-6):285-92; discussion 292-4. PubMed ID: 9988934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel (Taxotere): a highly active taxoid with manageable toxicity.
    Aapro MS
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):1-2. PubMed ID: 7740325
    [No Abstract]   [Full Text] [Related]  

  • 38. Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients.
    Altundag K; Altundag O; Boruban C; Altundag MB; Turen S
    Med Hypotheses; 2006; 66(1):211-2. PubMed ID: 15950399
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrotubular and cytotoxic activity of geiparvarin analogues, alone and in combination with paclitaxel.
    Miglietta A; Bocca C; Gabriel L; Rampa A; Bisi A; Valenti P
    Cell Biochem Funct; 2001 Sep; 19(3):181-9. PubMed ID: 11494307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 4: Pharmacology and other tumor types. Puerto Rico, March 12-16, 1997.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-113; quiz S19-114-S19-123. PubMed ID: 9446242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.